NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Hey Rk, quite true. I would suspect it is the same individual.

I did also notice that by June 11th, 9 had received at least 4 injections (week 0,1,2,8), and 20 had at least 3 (week 0,1,2). By Aug 11th therefore, we could conclude that 9 had received at least 5 injections (week 0,1,2,8,16), and 20 had at least 4 (week 0,1,2,8).

If they announced the Ph I leg was fully enrolled Jul 16, then these last enrolled patients should complete the regimen by Feb 2015 (then two months after that they would assess again. They do this every two months for 24 months provided they are surviving). I would imagine, considering the trial concludes June 2015, that the Ph II leg may begin to be enrolled some 8 weeks after the last enrollees to Ph I have received three doses, plus assessment. Maybe by October. And I suspect the lowest dose will be selected. No idea which indication. BUT, they may not even begin enrolling the Ph II leg until later than this.

In the PR it also states:

The Company plans to report more details when the patients are further along in the treatment regimen.

Which may still be on. I mean, what's the worst that could happen? AF gets another statement saying, "MD anderson still does not approve of sharing early data of an ongoing trial." Who cares?

Anyway, we just might receive another update on patient progress soon, in a couple months, or at a more "acceptable" interim moment, such as when the majority of the 36 patients have received all 6 vaccinations, plus some time for assessment of the last dose's effect (8 weeks thereafter). 20/36 would reach all 6 doses plus 8 weeks assessment by early winter.